Diverse AI with Rajvir Madan

Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders

The diverse applications of artificial intelligence are transforming industries at an unprecedented pace, but with great breakthroughs come complex challenges.
Today I'm joined by Rajvir Madan, Chief Digital and Technology Officer at Arcutis Biotherapeutics, to break down the transformative impact AI is having in our field.

Our discussion spans from the reduction of drug discovery timelines to addressing ethical concerns related to data biases. We also confront challenges tied to data quality and the implications for the workforce in the era of AI.
To grasp the full spectrum of AI's influence on biotech and the vision it's charting for our future, tune in for a compelling episode.

Specifically, this episode highlights the following themes:

• Dissecting AI impact on biotech
• AI benefits, cautious of challenges and ethics
• Addressing challenges in digital transformation for businesses

Links from this episode:

• Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
• Get to know more about Rajvir Madan: https://www.linkedin.com/in/rajvir-raj-madan-3a74252

Hoofdstukken

1. Introduction (00:00:00)

2. About Rajvir Madan (00:00:48)

3. Ensure accurate, reliable data for model refinement (00:05:49)

4. Companies leveraging genetic data to improve AI models (00:07:56)

5. Underutilized medical data sets need proper mining (00:10:01)

6. Engineer emphasizes problem-focused approach to AI (00:13:09)

7. Generative AI hype may not be necessary (00:19:18)

8. Simplified definition of generative AI and models (00:20:42)

9. Technology trends: AI, AR, VR, metaverse, quantum computing (00:24:29)

10. Growing up Indian, learning self-advocacy, promoting diversity (00:28:15)

11. Caution needed with rapid growth of technology (00:33:02)